Atherosclerosis· 2019Q1
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
- 4,872citations
- Q1SCImago
- 2019year
Short summary
These guidelines update recommendations for managing dyslipidaemias to reduce cardiovascular risk, emphasizing lipid modification strategies.
AI-generated from the title and abstract; the full text is not read.
Key points
- Updated guidelines for dyslipidaemia management.
- Focus on lipid modification for cardiovascular risk reduction.
- Provides a framework for clinical decision-making.
AI-generated from the title and abstract; the full text is not read.
Abstract
Correction: Volume: 292 Pages: 160-162 DOI: 10.1016/j.atherosclerosis.2019.11.020 Published: JAN 2020
The authors' abstract, as published at the source. Atherosclerosis, 2019 · DOI ↗
TakeawaysPremium
Ask the paperFree account
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Surgery
SurgeryMedicine